237 related articles for article (PubMed ID: 29978463)
1. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE
Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
Chen Y; Zhang L; Liu W; Liu X
Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.
Vangangelt KMH; van Pelt GW; Engels CC; Putter H; Liefers GJ; Smit VTHBM; Tollenaar RAEM; Kuppen PJK; Mesker WE
Breast Cancer Res Treat; 2018 Apr; 168(3):601-612. PubMed ID: 29273955
[TBL] [Abstract][Full Text] [Related]
6. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
7. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
8. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
9. An easy and practical prognostic parameter: tumor-stroma ratio in Luminal, Her2, and triple-negative breast cancers.
Öztürk Ç; Okcu O; Şen B; Bedir R
Rev Assoc Med Bras (1992); 2022 Feb; 68(2):227-233. PubMed ID: 35239887
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).
Dekker TJ; van de Velde CJ; van Pelt GW; Kroep JR; Julien JP; Smit VT; Tollenaar RA; Mesker WE
Breast Cancer Res Treat; 2013 Jun; 139(2):371-9. PubMed ID: 23709090
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
12. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study.
Roeke T; Sobral-Leite M; Dekker TJA; Wesseling J; Smit VTHBM; Tollenaar RAEM; Schmidt MK; Mesker WE
Breast Cancer Res Treat; 2017 Nov; 166(2):435-445. PubMed ID: 28795248
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological correlation of tumor-stroma ratio and inflammatory cell infiltrate with tumor grade and lymph node metastasis in squamous cell carcinoma of buccal mucosa and tongue in 41 cases with review of literature.
Rani P; Gupta AJ; Mehrol C; Singh M; Khurana N; Passey JC
J Cancer Res Ther; 2020; 16(3):445-451. PubMed ID: 32719249
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
18. The Breast Tumor Strain Ratio Is a Predictive Parameter for Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer.
Kim JY; Shin JK; Lee SH
AJR Am J Roentgenol; 2015 Dec; 205(6):W630-8. PubMed ID: 26587952
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
20. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
